September 2026
The global small molecule API market size was valued at USD 217 billion in 2026 and is projected to surpass around USD 347.45 billion by 2035 with a CAGR of 5.38%.
June 2026
The global synthetic small molecule API market size is estimated to hit around USD 342.63 billion by 2035 increasing from USD 208.51 billion in 2026, with a CAGR of 5.68%.
December 2025
The global outsourced small-molecule API manufacturing market grows as pharma companies partner with CDMOs for cost-efficient, scalable, and compliant API production.t
September 2026
The global small molecule immunomodulators market size is projected to hit around USD 339.54 billion by 2035 from USD 198.69 billion by 2026, at a CAGR of 6.14%.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
September 2026
The global peptide api market size is estimated to hit around USD 100.16 billion by 2035, increasing from USD 65.08 billion in 2026, with a CAGR of 4.91%.
September 2026
The rapid microbiology testing market size was USD 7.37 billion in 2026, with leading rapid microbiology testing market players including Creative Diagnostics, bioMérieux, Synbiosis, Thermo Fisher Scientific,
September 2026
The small commercial vehicle market size was valued at USD 597.36 billion in 2026 and is projected to hit around USD 916.76 billion by 2034, expanding at a CAGR of 5.5%.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global rapid prototyping market size is calculated at USD 4.83 billion in 2026 and is projected to hit around USD 24.71 billion by 2035 with a CAGR of 19.94%.
September 2026
The global small SUVs market size is estimated at USD 560.63 billion in 2026 and is expected to hit around USD 590 billion by 2034 with a CAGR of 0.64%.
September 2026
The global human capital management market size is projected to surpass around USD 81.41 billion by 2035 from USD 34.37 billion in 2025 with a notable CAGR of 9.01%%.
September 2026
The cosmeceutical API market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The global pharmaceutical rapid microbiology testing market size is estimated to hit around USD 6.40 billion by 2035 from USD 1.32 billion in 2025, with a CAGR of 17.10%.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The global small UAV market size is valued at USD 9.49 billion in 2026 and is projected to hit around USD 40.15 billion by 2034 with a CAGR of 17.54%
September 2026
The global microbial API market size was valued at USD 62.66 billion in 2024 and is projected to surpass around USD 108.59 billion by 2034, with a CAGR of 5.65%.
September 2026
The global small-scale LNG market size was evaluated at USD 78.18 billion in 2026 and is expected to attain around USD 250.63 billion by 2035, with a CAGR of 13.85%.
September 2026
The small nuclear reactor market reached USD 8.16 billion in 2026, featuring leading small nuclear reactor market companies such as Deutsche Post DHL Group, United Parcel Service (UPS), FedEx Corporation, Kuehne + Nagel, DB Schenker.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The chemical API CDMO market size was USD 18.36 billion in 2026, with leading chemical API CDMO market players including Lonza Group, WuXi AppTec, Samsung Biologics, Boehringer Ingelheim.
September 2026
The CAR-T therapies for blood cancers market generated USD 8.09 billion in 2026, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
September 2026
The global small hydropower market size was evaluated at USD 2.39 billion in 2026 and is projected to surpass around USD 3.07 billion by 2035 with a CAGR of 2.80%.
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
August 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
August 2026
The global small-scale bioreactors market size is calculated at USD 2.92 billion in 2025 and is projected to hit around USD 10.56 billion by 2035 with a CAGR of 13.72%
July 2026
The small caliber ammunition market size is evaluated at USD 10.31 billion in 2025 and is expected to hit around USD 15.08 billion by 2035 with a CAGR of 3.77%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com